Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alimu Dayimu

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
BMJ Mental Health|October 29, 2025
Identifying modifiable factors and their joint associations on late-onset schizophrenia risk in the UK Biobank: a prospective exposure-wide association studyFan Jiang, Qiuyue Dong, Emilio Fernandez-Egea, et al.
Journal of Personalized Medicine|March 29, 2023
Refining the Intraoperative Identification of Suspected High-Grade Glioma Using a Surgical Fluorescence Biomarker: GALA BIDD Study ReportColin Watts, Alimu Dayimu, Tomasz Matys, et al.
British Journal of Cancer|February 22, 2023
Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinomaAlimu Dayimu, Lorena Di Lisio, Shubha Anand, et al.
BMJ Open|August 22, 2024
Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington's disease (FELL-HD): a phase II, single-centre, open-label, dose-finding trial protocolKatie Andresen, Emma Cutting, Dimitrios Apostolopoulos, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|December 2, 2016
[Association between hematocrit and risk of incident hypertension: a cohort study]Y F Chen, C X Wang, Z S Yuan, et al.
BMC Medicine|November 7, 2024
A comprehensive evaluation on the associations between hearing and vision impairments and risk of all-cause and cause-specific dementia: results from cohort study, meta-analysis and Mendelian randomization studyFan Jiang, Qiuyue Dong, Sijia Wu, et al.
The Laryngoscope|July 3, 2025
A Trial of Semicircular Canal Plugging vs. Intratympanic Gentamicin for Menière's DiseaseDaogong Zhang, Xiaofei Li, Raymond Van de Berg, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2023
Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanomaIshan Mehta, Alimu Dayimu, Satish Kumar, et al.
Cell Reports. Medicine|May 13, 2026
Hearing aid effectiveness and probable dementia risk across 33 countries: A pooled analysis of seven cohortsFan Jiang, Qiuyue Dong, Dona M P Jayakody, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2023
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF<sup>V600</sup> mutant advanced melanoma (INTERIM)Alimu Dayimu, Avinash Gupta, Rubeta N Matin, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
BMJ Mental Health|October 29, 2025
Identifying modifiable factors and their joint associations on late-onset schizophrenia risk in the UK Biobank: a prospective exposure-wide association studyFan Jiang, Qiuyue Dong, Emilio Fernandez-Egea, et al.
Journal of Personalized Medicine|March 29, 2023
Refining the Intraoperative Identification of Suspected High-Grade Glioma Using a Surgical Fluorescence Biomarker: GALA BIDD Study ReportColin Watts, Alimu Dayimu, Tomasz Matys, et al.
British Journal of Cancer|February 22, 2023
Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinomaAlimu Dayimu, Lorena Di Lisio, Shubha Anand, et al.
BMJ Open|August 22, 2024
Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington's disease (FELL-HD): a phase II, single-centre, open-label, dose-finding trial protocolKatie Andresen, Emma Cutting, Dimitrios Apostolopoulos, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|December 2, 2016
[Association between hematocrit and risk of incident hypertension: a cohort study]Y F Chen, C X Wang, Z S Yuan, et al.
BMC Medicine|November 7, 2024
A comprehensive evaluation on the associations between hearing and vision impairments and risk of all-cause and cause-specific dementia: results from cohort study, meta-analysis and Mendelian randomization studyFan Jiang, Qiuyue Dong, Sijia Wu, et al.
The Laryngoscope|July 3, 2025
A Trial of Semicircular Canal Plugging vs. Intratympanic Gentamicin for Menière's DiseaseDaogong Zhang, Xiaofei Li, Raymond Van de Berg, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2023
Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanomaIshan Mehta, Alimu Dayimu, Satish Kumar, et al.
Cell Reports. Medicine|May 13, 2026
Hearing aid effectiveness and probable dementia risk across 33 countries: A pooled analysis of seven cohortsFan Jiang, Qiuyue Dong, Dona M P Jayakody, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2023
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF<sup>V600</sup> mutant advanced melanoma (INTERIM)Alimu Dayimu, Avinash Gupta, Rubeta N Matin, et al.
Pageof 3